发明名称 |
Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist |
摘要 |
Compositions and methods for the therapy of Inflammatory Bowel Disease (IBD), including Celiac Disease, Crohn's Disease, and Ulcerative Colitis, are disclosed. Illustrative compositions comprise one or more anti-type 1 interferon antagonists, such as anti-type 1 interferon receptor antibody antagonists and fragments thereof, as well as polypeptides and small molecules that inhibit the interaction of type 1 interferon with its receptor (IFNAR). |
申请公布号 |
US8828393(B2) |
申请公布日期 |
2014.09.09 |
申请号 |
US201113050601 |
申请日期 |
2011.03.17 |
申请人 |
Medarex, L.L.C. |
发明人 |
Pickford Lesley B.;Bebbington Christopher R.;Yarranton Geoffrey T.;King David |
分类号 |
A61K39/395;C07K16/28;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
Baker Botts L.L.P. |
代理人 |
Baker Botts L.L.P. |
主权项 |
1. A method of treating a patient afflicted with Crohn's disease or ulcerative colitis, comprising (a) administering to said patient at a first time point a tolerizing dose of a first type 1 interferon antagonist which is a chimeric, humanized or human anti-type 1 interferon receptor antibody, and (b) administering to said patient at a second time point a therapeutically effective dose of a second type 1 interferon antagonist which is an anti-type 1 interferon alpha antibody. |
地址 |
Princeton NJ US |